JB Chemicals & Pharmaceuticals Limited — PPTs, 30-06-2025: Investor Presentation

1. Financial Highlights:

JB Chemicals delivered a revenue CAGR of 18% from FY21 to FY25 with strong contribution from India (58%) driven by 6 brands in the IPM Top 300 and 3 in cardiology’s Top 25. Torrent Pharmaceuticals grew revenue at a CAGR of 10% over the same period, with 56% revenue from India and key markets including the US, Brazil, and Germany. Combined, the merged entity boasts over INR 15,000 Cr in revenue and INR 4,800 Cr in EBITDA, positioning it as the 5th largest pharma player in India by secondary sales and 4th by prescriptions.

2. Strategic Initiatives & Growth Drivers:

The merger aims to strengthen brand equity and portfolio depth, with a strategic focus on high-growth therapeutic areas like cardiology and gastroenterology. JB Pharma’s chronic disease brand leadership complements Torrent’s specialty focus, driving diversified revenue streams. The combined entity is expected to leverage operational synergies across markets, manufacturing, and product innovation to fuel sustainable long-term growth.

3. Business Developments:

Torrent acquired a 46.39% stake in JB Pharma for INR 11,917 Cr through a Share Purchase Agreement, triggering a mandatory tender offer. The merger will consolidate their presence under Torrent as the surviving listed entity, unlocking scale benefits and creating a stronger integrated platform.

4. Market Position & Competitive Advantage:

Post-merger, the entity ranks 5th in India’s IPM by secondary sales and 4th by prescription volume, with a combined market share around 3.3-3.4%. Scale advantages, a multi-therapeutic portfolio, and presence in 40+ (JB Pharma) and 50+ (Torrent) countries enhance its leadership and competitive moat.

5. Investor Implications:

The deal signals positive growth potential driven by enhanced market reach, portfolio synergies, and operational efficiencies. Execution risk remains on successful merger integration and regulatory approvals, but the combined scale and diversified footprint offer an attractive platform for sustainable value creation.